{"speaker":{"id":3777,"title":"","firstname":"Matthias","middleinitial":"","lastname":"M\u00fcllenbeck","description":"Business developer","whotheyare":"As the Biopharma director for licensing and business development at Merck KGaA, Darmstadt, Germany, Matthias M\u00fcllenbeck is responsible for leading strategic partnering initiatives in the field of oncology and immuno-oncology.","whylisten":"<p>Throughout his career in various roles at Merck KGaA, Darmstadt, Germany, Matthias M&uuml;llenbeck worked on strategic asset, technology and diagnostic-licensing deals and on bringing to market innovative chemical products. He holds a PhD in immunology from the Humboldt University in Berlin and has worked at the Max-Planck Institute for infection biology in Berlin, at Bayer, and at the Albert-Schweizer Hospital in Lambaran&eacute;, Gabon.<\/p>","slug":"matthias_muellenbeck","published_at":"2017-11-15 22:39:00","updated_at":"2018-03-26 18:33:47"}}